China Dasheng Biotechnology Company
China Dasheng Biotechnology Company (CDBT) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001393067 · CDBT · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001393067 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
China Dasheng Biotechnology Company (OTC: CDBT) has submitted 44 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Financial Services sector company with CIK 0001393067, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is China Dasheng Biotechnology Company's most comprehensive regulatory disclosure. The most recent China Dasheng Biotechnology Company 10-K was filed on 2008-10-24 for fiscal year ending 2008. Historical CDBT 10-K annual reports are available from 2007 through 2008.
Investors researching China Dasheng Biotechnology Company SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CDBT SEC Filings · 8 questionsChina Dasheng Biotechnology Company (CDBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 44 filings and access original documents at no cost. China Dasheng Biotechnology Company's CIK is 0001393067.